| Title |
miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]
|
|---|---|
| Published in |
OncoTargets and therapy, March 2022
|
| DOI | 10.2147/ott.s364549 |
| Pubmed ID | |
| Authors |
Hangzhou Wang, Xue-tao Li, Chun Wu, Zhi-wu Wu, Yan-yan Li, Tian-quan Yang, Gui-lin Chen, Xue-shun Xie, Yu-lun Huang, Zi-wei Du, Yo-xin Zhou |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2022.
All research outputs
#15,181,325
of 25,392,582 outputs
Outputs from OncoTargets and therapy
#781
of 3,016 outputs
Outputs of similar age
#210,922
of 449,877 outputs
Outputs of similar age from OncoTargets and therapy
#12
of 20 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,877 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.